[Interferon-alpha directly inhibits thrombopoietin-induced megakaryocyte proliferation and differentiation]
- PMID: 11877087
[Interferon-alpha directly inhibits thrombopoietin-induced megakaryocyte proliferation and differentiation]
Abstract
Objective: To characterize the inhibitory effect of interferon-alpha (IFN-alpha) on megakaryocyte proliferation and differentiation stimulated by thrombopoietin (Tpo).
Methods: Normal murine megakaryocytes were prepared by three different cell purification procedures. Megakaryocyte development was studied by semi-solid and suspension cultures and assessed with megakaryocyte colony forming unit (CFU-MK), acetylcholinesterase activity (AChE) as well as megakaryocyte count, diameter and DNA content.
Results: IFN-alpha prohibited CFU-MK formation and decreased AChE of megakaryocytes. The inhibitory effects were positively related to doses of IFN-alpha and could not be overcome by escalating exogenous Tpo or depriving accessory cells in bone marrow culture. IFN-alpha affected all aspects of megakaryocyte development, including decreases in megakaryocyte count, diameter and geometric mean polyploidy.
Conclusion: IFN-alpha directly inhibits Tpo-induced megakaryocyte proliferation and differentiation in a dose-dependent manner.
Similar articles
-
Disparate effects of interleukin 11 and thrombopoietin on megakaryocytopoiesis in vitro.Cytokine. 2001 Sep 7;15(5):241-9. doi: 10.1006/cyto.2001.0928. Cytokine. 2001. PMID: 11594788
-
Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.Exp Hematol. 1997 Feb;25(2):169-76. Exp Hematol. 1997. PMID: 9015217
-
Differential effects of a novel IFN-zeta/limitin and IFN-alpha on signals for Daxx induction and Crk phosphorylation that couple with growth control of megakaryocytes.Exp Hematol. 2005 Apr;33(4):495-503. doi: 10.1016/j.exphem.2005.01.002. Exp Hematol. 2005. PMID: 15781341
-
Physiologic role of TPO in thrombopoiesis.Stem Cells. 1996;14 Suppl 1:133-8. doi: 10.1002/stem.5530140717. Stem Cells. 1996. PMID: 11012213 Review.
-
Do the preclinical effects of thrombopoietin correlate with its in vitro properties?Stem Cells. 1996;14 Suppl 1:108-11. doi: 10.1002/stem.5530140713. Stem Cells. 1996. PMID: 11012209 Review.
Cited by
-
Current knowledge of thrombocytopenia in sepsis and COVID-19.Front Immunol. 2023 Sep 28;14:1213510. doi: 10.3389/fimmu.2023.1213510. eCollection 2023. Front Immunol. 2023. PMID: 37841241 Free PMC article. Review.
-
Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity.Int Immunopharmacol. 2021 Oct;99:107995. doi: 10.1016/j.intimp.2021.107995. Epub 2021 Jul 21. Int Immunopharmacol. 2021. PMID: 34304001 Free PMC article. Review.
-
Mechanisms involved in the development of thrombocytopenia in patients with COVID-19.Thromb Res. 2020 Sep;193:110-115. doi: 10.1016/j.thromres.2020.06.008. Epub 2020 Jun 5. Thromb Res. 2020. PMID: 32535232 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
